Table 3 Neonatal neurodevelopmental outcomes following escalating doses HFA-BDPa
From: Inhaled corticosteroids in ventilated preterm neonates: a non-randomized dose-ranging study
Dose | Total Number Assessed | Cerebral palsy, n (%) | Normal or mild cognitive impairment, n (%) | Severe cognitive impairment, n (%) |
|---|---|---|---|---|
200 μg bid (n = 11) | 10 | 1/10 (10) | 9 (90) | 1 (10) |
400 μg bid (n = 11) | 10 | 1/10 (10) | 9 (90) | 1 (10) |
600 μg bid (n = 10) | 9 | 0/9 (0) | 9 (100) | 0 (0) |
800 μg bid (n = 9) | 8 | 1/8 (12.5) | 6 (75) | 2 (25) |